文献速递瓣膜外科

自膨胀瓣膜经直接主动脉入路行TAVR的预后分析

Direct Aortic Access for Transcatheter Aortic Valve Replacement Using a Self-Expanding Device.
PubMed 文献 · Ann Thorac Surg · 2017-11-22

该研究基于CoreValve美国高危/极高危关键试验及继续准入研究,采用倾向性评分匹配比较经直接主动脉(DA)与经股动脉(IF)入路行自膨胀瓣膜TAVR的结局。共匹配394对患者,DA组30天全因死亡率(10.9% vs 4.1%)及30天、1年全因死亡或主要卒中(13.5% vs 5.3%;30.4% vs 24.2%)显著更高,30天严重/危及生命出血和急性肾损伤亦显著增加。结论认为股动脉不可行时DA入路可有效释放瓣膜但不良事件风险增加。

要点

  • 股动脉入路不可行时,直接主动脉入路可有效完成自膨胀瓣膜TAVR。
  • DA组30天全因死亡率10.9%,显著高于IF组4.1%(p<0.001)。
  • DA组30天严重/危及生命出血66.7%、急性肾损伤19.7%,均显著高于IF组。

核心结论

  • 股动脉入路不可行时,直接主动脉入路可有效释放自膨胀瓣膜,但死亡及不良事件风险增加,可能与操作差异有关。

研究设计与样本

  • 回顾性比较研究,纳入CoreValve美国高危/极高危关键试验及继续准入研究中经直接主动脉或经股动脉行自膨胀瓣膜TAVR的患者。
  • 采用倾向性评分匹配平衡基线特征,共匹配394对IF与DA患者,比较30天和1年临床结局。

主要发现

  • DA组30天全因死亡率显著高于IF组(10.9% vs 4.1%,p<0.001),1年时差异减小(28.1% vs 23.2%,p=0.063)。
  • DA组30天全因死亡或主要卒中显著高于IF组(13.5% vs 5.3%,p<0.001),1年时仍显著更高(30.4% vs 24.2%,p=0.025)。
  • DA组30天严重/危及生命出血(66.7% vs 35.4%)和急性肾损伤(19.7% vs 10.0%)均显著高于IF组(均p<0.001)。

临床怎么用

  • 股动脉入路不可行的高危TAVR患者可考虑直接主动脉入路,但需充分评估其较高的死亡、出血及急性肾损伤风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transcatheter aortic valve replacement (TAVR) using a self-expanding valve has been shown to be superior to an open operation in high-risk patients. Extensive iliofemoral peripheral vascular disease can prohibit femoral access. In these cases, direct aortic (DA) implantation may be a suitable option. METHODS: The current analysis compared outcomes in patients undergoing TAVR with the self-expanding CoreValve prosthesis (Medtronic, Minneapolis, MN) by direct aortic (DA) access vs iliofemoral (IF) access. Patients treated in the CoreValve US High Risk and Extreme Risk Pivotal Trials and Continued Access Study were included. Propensity score matching was used to account for differences in baseline characteristics between groups. Clinical outcomes were compared at 30 days and 1 year. RESULTS: We identified 394 matched pairs of IF and DA patients. The all-cause mortality rate was significantly higher in the DA group than in the IF group at 30 days (10.9% vs 4.1%, p < 0.001), but this difference was reduced at 1 year (28.1% vs 23.2%, p = 0.063). All-cause mortality or major stroke was significantly higher for DA vs IF access at 30 days (13.5% vs 5.3%, p < 0.001) and at 1 year (30.4% vs 24.2%, p = 0.025). Major/life-threatening bleeding and acute kidney injury were significantly greater in the DA group at 30 days (66.7% vs 35.4% and 19.7% vs 10.0%, respectively, both p < 0.001). CONCLUSIONS: When femoral access is not feasible, DA access allows effective delivery of the valve but incurs an increased risk of death and adverse events, potentially the result of procedural differences.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. O'Hair DP, Bajwa TK, Popma JJ, et al. Direct Aortic Access for Transcatheter Aortic Valve Replacement Using a Self-Expanding Device. Ann Thorac Surg. 2017. PMID: 29174390. doi:10.1016/j.athoracsur.2017.07.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。